Related Experiment Videos
Scar wars strategies. Target collagen.
The Journal of Dermatologic Surgery and Oncology
|November 1, 1992
Summary
Pharmacologic strategies targeting collagen metabolism show promise for treating hypertrophic scars and keloids. Research into amino-acid analogs, interferons, and cytokine interference may lead to improved therapies for these challenging skin conditions.
Area of Science:
- Dermatology
- Pharmacology
- Biochemistry
Background:
- Hypertrophic scarring and keloid formation represent significant clinical challenges with limited effective treatments.
- Current therapeutic options for these conditions are often insufficient, necessitating novel approaches.
Purpose of the Study:
- To explore promising pharmacologic strategies for managing hypertrophic scars and keloids.
- To focus on treatments that specifically target collagen metabolism and extracellular matrix regulation.
Main Methods:
- Review of laboratory investigations on amino-acid analogs, procollagen peptides, D-penicillamine, and pentoxifylline.
- Analysis of clinical trial data for intralesional interferons in keloid treatment.
- Discussion of targeting cytokines like TGF-beta and related molecules.
Main Results:
- Amino-acid analogs, procollagen peptides, D-penicillamine, and pentoxifylline demonstrated inhibition of collagen synthesis in preclinical studies.
- Intralesional interferons showed significant reductions in keloid size and collagen production in clinical trials.
- Interference with extracellular matrix-enhancing cytokines presents a potential therapeutic avenue.
Conclusions:
- Pharmacologic agents targeting collagen metabolism offer a promising strategy for treating hypertrophic scars and keloids.
- Further research into cytokine modulation and related molecules could yield more effective therapeutic agents for scar management.